| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QAD.0B013E328347F6F7 |
| P698 | PubMed publication ID | 21522006 |
| P50 | author | Josep Maria Gatell | Q17030537 |
| Jens Lundgren | Q42325404 | ||
| Jean-Claude Souberbielle | Q43098269 | ||
| Amanda Mocroft | Q47006497 | ||
| Brygida Knysz | Q58302731 | ||
| Marcelo Losso | Q88031028 | ||
| Ole Kirk | Q102213445 | ||
| Jean-Paul Viard | Q114452117 | ||
| Joanne Reekie | Q114720205 | ||
| P2093 | author name string | Court Pedersen | |
| Johannes R Bogner | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| vitamin D | Q175621 | ||
| P304 | page(s) | 1305-1315 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study | |
| P478 | volume | 25 |
| Q34076892 | 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings |
| Q35892921 | A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection |
| Q37288171 | Adjudication of the alleged role of vitamin d in the antimicrobial pathway |
| Q27011921 | Anti-Inflammatory and Antimicrobial Actions of Vitamin D in Combating TB/HIV |
| Q34994918 | Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study |
| Q40874258 | Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV. |
| Q38540406 | Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient |
| Q38095828 | Bone health and human immunodeficiency virus infection |
| Q36882631 | Bone health in HIV-infected children and adolescents |
| Q40461045 | Change in serum 25-hydroxyvitamin D with antiretroviral treatment initiation and nutritional intervention in HIV-positive adults. |
| Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
| Q38973122 | Changes in bone turnover markers with HIV seroconversion and ART initiation |
| Q54224147 | Continued Interest and Controversy: Vitamin D in HIV. |
| Q36736469 | Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. |
| Q42230910 | Different strategies of 25OH vitamin D supplementation in HIV-positive subjects |
| Q41644519 | Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients |
| Q62489966 | Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial |
| Q40058675 | Effect of maternal vitamin D3 supplementation on maternal health, birth outcomes, and infant growth among HIV-infected Tanzanian pregnant women: study protocol for a randomized controlled trial |
| Q38978858 | Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth |
| Q97073458 | Efficacy of vitamin D3 supplementation for the prevention of pulmonary tuberculosis and mortality in HIV: a randomised, double-blind, placebo-controlled trial |
| Q37635220 | Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial |
| Q38413754 | HIV infection : chronic disease with comorbidities |
| Q34420382 | HIV life cycle, innate immunity and autophagy in the central nervous system |
| Q34116873 | Habitual nutrient intake in HIV-infected youth and associations with HIV-related factors |
| Q39673591 | High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions? |
| Q34799320 | High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial |
| Q54217927 | Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study. |
| Q36177899 | Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York. |
| Q45024589 | Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV-infected patients. |
| Q27005938 | Inhibition of human immunodeficiency virus type-1 through autophagy |
| Q36381307 | Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals. |
| Q33828335 | LL-37 concentrations and the relationship to vitamin D, immune status, and inflammation in HIV-infected children and young adults |
| Q33761301 | Micronutrient supplementation in adults with HIV infection. |
| Q36225293 | No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults |
| Q33781248 | Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy |
| Q37156878 | Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona. |
| Q40563423 | Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study |
| Q37249960 | Prevalence of vitamin D deficiency among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy |
| Q42229887 | Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons |
| Q35571275 | Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa |
| Q35451868 | Recommendations for evaluation and management of bone disease in HIV. |
| Q33804189 | Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe |
| Q38450420 | Risk factors associated with hypovitaminosis D in HIV/aids-infected adults. |
| Q35510622 | Risk factors for vitamin D deficiency among veterans with and without HIV infection |
| Q37029416 | Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth |
| Q38210581 | Role of vitamin D in acquired immune and autoimmune diseases |
| Q36862311 | Safety and Efficacy of High-Dose Daily Vitamin D3 Supplementation in Children and Young Adults Infected With Human Immunodeficiency Virus |
| Q34538265 | Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients |
| Q37111446 | Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women |
| Q37382387 | T cell susceptibility to HIV influences outcome of opportunistic infections |
| Q90705218 | The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection |
| Q59352745 | The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co-infection in the development of hypovitaminosis D in adults |
| Q28485225 | Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1 |
| Q41659730 | Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus |
| Q37980739 | Update of the past year: a review from IDSA 2011. |
| Q37267250 | Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection. |
| Q40517679 | Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study |
| Q40519915 | Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder |
| Q36656763 | Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy |
| Q34328579 | Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy |
| Q39026377 | Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? |
| Q47855511 | Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians |
| Q37145285 | Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion |
| Q34016783 | Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals |
| Q36408936 | Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort |
| Q42287386 | Vitamin D deficiency is common among HIV-infected breastfeeding mothers in Pune, India, but is not associated with mother-to-child HIV transmission |
| Q90597697 | Vitamin D deficiency or supplementation and the risk of human herpesvirus infections or reactivation: a systematic review protocol |
| Q55283531 | Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. |
| Q28483647 | Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy |
| Q33615509 | Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV |
| Q38663355 | Vitamin D levels and their impact on mineral metabolism in HIV infected patients: an exploratory study |
| Q36404711 | Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden |
| Q37077101 | Vitamin D status in cats with feline immunodeficiency virus |
| Q34684189 | Vitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants |
| Q47829963 | Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. |
| Q33603196 | Vitamin D, bone, and HIV infection. |
| Q37265049 | Vitamin D-related host genetic variants alter HIV disease progression in children |
| Q36792991 | Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol |
| Q38857718 | Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study |
Search more.